Zobrazeno 1 - 10
of 85
pro vyhledávání: '"M. C. Nahata"'
Autor:
R. Taneja, M. C. Nahata, J. Scarim, P. G. Pande, A. Scarim, G. Hoddinott, C. L. Fourie, R. K. Jew, H. S. Schaaf, A. J. Garcia-Prats, A. C. Hesseling
Publikováno v:
The International Journal of Tuberculosis and Lung Disease. 27:189-194
BACKGROUND: Bedaquiline (BDQ) tablets are indicated as part of a combination regimen for the treatment of multidrug-resistant TB in adults, adolescents and children. A dispersible tablet formulation is now approved but is not currently available in a
Autor:
R. Taneja, M. C. Nahata, J. Scarim, P. G. Pande, A. Scarim, G. Hoddinott, C. L. Fourie, R. K. Jew, H. S. Schaaf, A. C. Hesseling, A. J. Garcia-Prats
Publikováno v:
The International Journal of Tuberculosis and Lung Disease. 27:106-112
BACKGROUND: Clofazimine (CFZ) is routinely used worldwide for the treatment of leprosy and TB. However, no liquid or dispersible tablet formulations of CFZ are currently available commercially for patients with challenges ingesting soft gelatin capsu
Autor:
R. Taneja, M. C. Nahata, J. Scarim, P. G. Pande, A. Scarim, G. Hoddinott, C. L. Fourie, R. K. Jew, H. S. Schaaf, A. J. Garcia-Prats, A. C. Hesseling
Publikováno v:
The International Journal of Tuberculosis and Lung Disease. 27:13-18
BACKGROUND: Delamanid (DLM) tablets are recommended for the treatment of rifampicin-resistant TB. However, no liquid or dispersible tablet formulation of DLM is currently commercially available for patients with challenges ingesting these tablets. Th
Autor:
M C Nahata, M E Temple
Publikováno v:
Alimentary Pharmacology & Therapeutics. 14:421-425
Objective: To compare the palatability, acid neutralizing capability, and costs of different antacids. Methods: Volunteers between the ages of 18 and 60 years were given 22 antacids. All antacids were given during a 4-h period in two groups of 11 ant
Autor:
M C, Nahata
Publikováno v:
International journal of pharmaceutical compounding. 3(4)
Autor:
M. C. Nahata, J. L. Bootman, Z. Zadák, P. B. Soeters, Laurence A. Goldberg, S. Stremetzne, U. Jaehde, M. Streit, E. D. Kreuser, E. Thiel, W. Schunack, R. T. Calvert, M. Feely, H. Chrystyn, M. A. Mangues, G. Ginovart, M. A. Moral, A. P. Lopes, R. Farré, X. Demestre, O. Altirriba, Ch. Kloft, J. Beyer, J. Steuer, W. Siegert, J. Bever, M. Bialer, S. Sussan, O. Abu Salach, H. D. Danenberg, A. Laor, M. I. Barnett, A. G. Cosslett, J. Cohen, P. Marini, C. Bassi, A. Bonzanini, T. Cassani, G. Ore, G. Mangiante, G. Scroccaro, M. Kaczan, J. Eriksen, B. Toft, M. Jandová, J. Vlček, V. Klemerová, L. Sobotka, A. Ayestarán, R. López, J. B. Montoro, L. Pou, A. Estíbalez, B. Pascual, M. D. Aumente, M. D. Panadero, M. Caraballo, J. C. Pozo, J. L. Perez, A. C. Falcão, M. M. Fernández de Gatta, A. Dominguez-Gil, M. M. Caramona, J. M. Lanao, Z. Fendrich, J. Zajic, Medall M. D. Bellés, Alós V. G. Casabó, Torres N. V. Jiménez, Botella M. A. Hervás, Gimeno F. J. Abad, Melchor D. E. Casterá, M. Aminian, A. Clopés, C. Branco, I. Badell, N. Pardo, C. Palací, J. Bonal, G. Rialp, B. Bara, M. Nobilis, V. Bláha, E. Havel, J. Květina, M. Brátová, D. Solichová, M. Mullerova, D. Svoboda, M. Pokrajac, B. Miljković, D. Simić, B. Brzaković, A. Galetin, R. L. Pinheiro, A. P. Carrondo, E. Sieradzki, K. Strauss, E. Olejarz, A. Marzec, J. Kaużny, J. Szymura-Oleksiak, E. Wyska, B. Jarosz, I. Kosowicz, K. Fabirkiewicz, R. Cherian, A. -L. Vodoz, B. Imsand, D. Belli, Th. Rochat, H. Müllerová, F. Falcão, A. Carvalho, T. Pereira, C. Fonseca, O. Freitas, M. Resende, A. Parrinha, M. Costa, M. A. Pessanha, A. Ferreira, L. Mourão, F. Ceia, Mendonça Lima, R. Tavares, A. SalesLuis, Santos Carlos, M. E. Araújo Pereira, J. Alves do Carmo, J. M. Forjaz Lacerda, J. A. Morais, C. Beaufils, M. Duff, P. Zamparutti, P. Assicot, M. Bohor, B. Angelini, M. Lambert, J. C. Manelli, A. Gayte-Sorbier, M. C. Bongrand, P. Timon-David, I. C. Fiqueira, R. Lourenco, P. A. Silva, M. O. Rodrigues, A. Fischer, W. Schorr, R. Radziwill, M. Lihtamo, A. Jäppinen, K. Tuovinen, M. Pekkala, L. Nuutinen, L. Morató, L. Lorente, J. Muñoz, Ph Monges, A. Blancard, B. Lacarelle, J. P. Denis, M. -C. Bongrand, Ch Penot-Ragon, F. Gouin, Nicole Petitcollot, I. Tinguely, J. Beney, S. Marty, J. -Ph. Reymond, J. Bussels, H. Robays, A. Litzinger, R. Rohda-Bohler, M. S. Salek, S. Turpin, E. Derby, B. Millar, C. Maggs, L. M. Santiago, Marques Batel, G. Cajaraville, M. J. Tarnés, M. J. Díaz, C. Pozo, A. Plazaola, M. Vuelta, E. Díaz-Munío, A. Ferrer, A. Lozano, R. Guerra, J. L. Pontón, K. Kint, A. Verstraetep, D. El Eini, R. K. Ojala, K. M. Kontra, T. J. P. Naaranlahti, M. Martorell, M. Oliveras, C. Juste, M. T. Lopez, E. Hidalgo, M. J. Cabañas, C. Barroso, J. M. Llop, M. Rey, E. Diaz-Munio, L. Pastó, M. Tubau, M. J. Gómez-Bellver, J. Rodriguez, J. M. Gómez, M. L. Gónzalez, V. Gol, V. Fuentes, S. Ramón, L. Girona, T. Castelló, M. Olona, L. García, C. Girón, C. Monteserín, P. Gonzalez, C. Alberola, J. A. L. Feio, D. Pharm, F. J. Batel Marques, Alexandrino M. Borges, S. Salek, M. C. Escoms, I. Caro, N. Ticó, M. Hidalgo, R. Bruguera, R. Jodar, J. M. Dowell, P. G. Davey, M. Malek, M. Rev, I. Ferrer, T. Marti, M. Ibars, J. P. Delporte, M. Ansseau, A. Albert, M. Sibourg, O. Gaspard, M. Deprez, H. M. Ndougsa, M. Poma, M. J. Tamés, K. Macek, M. Klejna, S. Dhillon, I. Castro, M. Newton, I. A. Zupanets, V. P. Chernyh, N. B. Bezdetko, S. B. Popov, M. N. Velieva, S. M. Babajeya, Y. D. Mamedov, Y. Dj. Mammedov, P. M. Veliev, A. A. Nasudari, A. A. Bandalieva, S. Nordbo, M. Smith-Solbakken, R. Myklctun, W. Berge, M. Thormodsen, L. A. Zupanets, L. S. Kicenko, S. I. Plusch, S. G. Isaev, L. Vokrouhlický, R. Souček, P. Kuneš, O. Nývlt, L. A. Potselueva, S. N. Egorova, E. A. Kadirova, L. E. Ziganshina, J. Chaloupka, K. Genger
Publikováno v:
Pharmacy World & Science
Autor:
K E, Trinkley, M C, Nahata
Publikováno v:
Journal of clinical pharmacy and therapeutics. 36(3)
The complexity and diversity of irritable bowel syndrome's (IBS) presentation make treatment difficult. Although there are reviews and guidelines for treating IBS, they focus on the efficacy of medications for IBS symptoms using high-priority endpoin
Autor:
S M, Wintermeyer, M C, Nahata
Publikováno v:
Otolaryngology–Head and Neck Surgery. 114:332-334
Because other known pathogens are frequently isolated with AXX, its clinical significance may be overlooked. AXX should not be considered a colonizer or contaminant, particularly in the presence of clinical signs and symptoms of infection. For a pedi
Publikováno v:
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 57(12)
The stability of propylthiouracil in two extemporaneously prepared suspensions at 4 and 25 degrees C was studied. Commercially available 50-mg propylthiouracil tablets were used to prepare suspensions in 1:1 Ora-Sweet:Ora-Plus and in 1:1 1% methylcel
Autor:
M C, Nahata
Publikováno v:
Pediatrics. 104(3 Pt 2)
Many drugs frequently used in infants and young children are not available in suitable dosage forms. Liquid dosage forms must be prepared extemporaneously, while using appropriate excipients. However, it is critical to determine the stability of vari